W van der Giessen
Overview
Explore the profile of W van der Giessen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sianos G, Hoye A, Saia F, van der Giessen W, Lemos P, de Feyter P, et al.
Heart
. 2005 Jun;
91(7):942-7.
PMID: 15958367
Objectives: To determine the long term outcome after intracoronary beta radiation therapy (IRT). Setting: Tertiary referral centre. Methods: The rate of major adverse cardiac events (MACE) was retrospectively determined in...
2.
BOLAND J, Corbeij H, van der Giessen W, Seabra-Gomes R, Suryapranata H, Wijns W, et al.
Int J Cardiovasc Intervent
. 2002 Nov;
3(4):215-225.
PMID: 12431346
AIMS: The BiodivYsio trade mark stent (Biocompatibles Ltd, Farnham, UK) is coated with a phosphorylcholine (PC)-containing copolymer to confer biocompatibility. The SOPHOS (Study Of PHosphorylcholine coating On Stents) study was...
3.
Serruys P, Sianos G, van der Giessen W, Bonnier H, Urban P, Wijns W, et al.
Eur Heart J
. 2002 Aug;
23(17):1351-9.
PMID: 12191746
Aims: The BRIE trial is a registry evaluating the safety and performance of (90)Sr delivered locally (Beta-Cath TM system of Novoste) to de-novo and restenotic lesions in patients with up...
4.
van Domburg R, Foley D, de Feyter P, van der Giessen W, van den Brand M, Serruys P
Eur Heart J
. 2001 Jun;
22(11):934-41.
PMID: 11428817
Aims: This study reports the clinical outcome, up to 17 years, of the first 856 consecutive patients treated by coronary angioplasty at a single centre and attempts to identify a...
5.
Kay I, Sabate M, Van Langenhove G, Costa M, Wardeh A, Gijzel A, et al.
Heart
. 2000 Mar;
83(3):332-7.
PMID: 10677416
Objective: To evaluate the healing of balloon induced coronary artery dissection in individuals who have received beta radiation treatment and to propose a new intravascular ultrasound (IVUS) dissection score to...
6.
van Domburg R, Foley D, de Jaegere P, de Feyter P, van den Brand M, van der Giessen W, et al.
Heart
. 1999 Sep;
82 Suppl 2:II27-34.
PMID: 10490586
Objective: To describe the long term clinical outcome (up to 11 years) after coronary stenting. Design: A single centre observational study encompassing 1000 consecutive patients with a first stent implantation...
7.
Serruys P, Van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, et al.
Lancet
. 1998 Sep;
352(9129):673-81.
PMID: 9728982
Background: The multicentre, randomised Benestent-II study investigated a strategy of implantation of a heparin-coated Palmar-Schatz stent plus antiplatelet drugs compared with the use of balloon angioplasty in selected patients with...
8.
Serruys P, Emanuelsson H, van der Giessen W, Lunn A, Kiemeney F, Macaya C, et al.
Circulation
. 1996 Feb;
93(3):412-22.
PMID: 8565157
Background: The purpose of the Benestent-II Pilot Study was to evaluate the safety of delaying and eliminating anticoagulant therapy in patients receiving a heparin-coated stent in conjunction with antiplatelet drugs....
9.
Camenzind E, Kint P, Di Mario C, Ligthart J, van der Giessen W, Boersma E, et al.
Circulation
. 1995 Nov;
92(9):2463-72.
PMID: 7586346
Background: Inefficacy of systemic drug administration for restenosis prevention may partially relate to insufficient local drug concentration. This study aimed to evaluate the acute feasibility and long-term outcome of using...
10.
Hugenholtz P, Lichtlen P, van der Giessen W, Becker A, NAYLER W, FLECKENSTEIN A, et al.
Eur Heart J
. 1986 Jul;
7(7):546-59.
PMID: 3530767
An overview is provided of current thinking regarding the origin(s) of atherosclerosis on the basis of clinical evidence, experimental models and pharmacological investigations with calcium antagonists. Because this group of...